Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone 1G.7J.1G) SynExpress pL-G-AR-X Modified CD8+ T cells (CAT#: ITS-1224-CR268)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 1G.7J.1G). We employs the Lentivirus (pL-GFP-AR-XbaI) vector components and the SynExpress system of the Single base pair Insertion/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CCL2
Clone
1G.7J.1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
pL
Effector Gene
AR
Insertion Sites
XbaI
Gene Modification
Insertion
Modification Domain
Single base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.96
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving